In the Molecular Oncology pillar, we use large genomic and transcriptomic databases to identify clinically applicable therapeutic options for patients with solid tumours who either currently have no suitable drug therapy or have developed resistance to available treatments. Our main…

The Biotechnology Pillar carries out diagnostic, therapeutic and technological developments. We are developing a laboratory-based (RT-real-time PCR) system and a point-of-care (RT-LAMP and CRISPR/Cas13a-based) test procedure for the DNA/RNA-based detection of pathogens. With the recombinant polymerases developed, we will have…